These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Adverse response to pegylated interferon therapy in two patients with chronic hepatitis C.
    Author: Thomas WL, Ramos F, Hospenthal DR.
    Journal: Hawaii Med J; 2003 Aug; 62(8):163-4. PubMed ID: 14533347.
    Abstract:
    Pegylated interferons have recently been approved for treatment of hepatitis C. The safety of these formulations is reported to be similar to that of non-pegylated interferon. We present two patients who experienced exacerbations of their liver disease following administration of pegylated interferon alfa-2b. Vigilant monitoring of patients treated with these new agents is recommended.
    [Abstract] [Full Text] [Related] [New Search]